Latest Articles
As an ER doc, the rise of chair care is frankly demoralizing - Ottawa Citizen
As an ER doc, the rise of chair care is frankly demoralizing Ottawa Citizen
Published: June 4, 2026, 8:09 a.m.
As an ER doc, the rise of chair care is frankly demoralizing | Leters to the Editor - Ottawa Citizen
As an ER doc, the rise of chair care is frankly demoralizing | Leters to the Editor Ottawa Citizen
Published: June 4, 2026, 8:09 a.m.
As an ER doc, the rise of chair care is frankly demoralizing | Letters to the Editor - Ottawa Citizen
As an ER doc, the rise of chair care is frankly demoralizing | Letters to the Editor Ottawa Citizen
Published: June 4, 2026, 8:09 a.m.
Maipl Therapeutics Advances Non-Hormonal Oral Endometriosis Therapy Targeting Prostaglandin F2α Receptor - Femtech Insider
Maipl Therapeutics Advances Non-Hormonal Oral Endometriosis Therapy Targeting Prostaglandin F2α Receptor Femtech Insider
Published: May 15, 2026, 11:33 a.m.
Maipl Therapeutics Reports Preclinical Progress for MA-4604, a Novel Oral Non-Hormonal Treatment of Endometriosis - Newswise
Maipl Therapeutics Reports Preclinical Progress for MA-4604, a Novel Oral Non-Hormonal Treatment of Endometriosis Newswise
Published: May 14, 2026, 12:40 p.m.
MDSO: Driver dies after crashing car into tree in Doral - WPLG Local 10
MDSO: Driver dies after crashing car into tree in Doral WPLG Local 10
Published: May 1, 2026, 11:37 a.m.
Oral-B iO Series 5 deal: $99.99 at Amazon - Mashable
Oral-B iO Series 5 deal: $99.99 at Amazon Mashable
Published: April 25, 2026, 9 a.m.
Efficacy and Safety of Vaginal Estradiol Hemihydrate as an Adjunct to Oral Estradiol Valerate in Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) Cycles: A Retrospective Study - Cureus
Efficacy and Safety of Vaginal Estradiol Hemihydrate as an Adjunct to Oral Estradiol Valerate in Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) Cycles: A Retrospective Study Cureus
Published: Feb. 27, 2026, 7:22 a.m.
Eli Lilly Builds $1.5 Billion Stockpile of Oral GLP-1 Drug as Study Shows 66% Drop in Endometrial Cancer Risk for Certain Patients - geneonline.com
Eli Lilly Builds $1.5 Billion Stockpile of Oral GLP-1 Drug as Study Shows 66% Drop in Endometrial Cancer Risk for Certain Patients geneonline.com
Published: Feb. 16, 2026, 10:55 a.m.
Oral Microcapsules Encapsulating Endometrial Regenerative Cell-Derived | IJN - Dove Medical Press
Oral Microcapsules Encapsulating Endometrial Regenerative Cell-Derived | IJN Dove Medical Press
Published: Feb. 2, 2026, 7:47 a.m.
Link copied to clipboard!